Description
RADIOPHARMACEUTICAL ISOTOPES FOR NUCLEAR MEDICINE AT SYRACUSE VAMC
Modification chain · 4 transactions
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2011-11-15+$0= $0
- Mod P000012012-12-01+$0= $0
- Mod P000022013-10-01+$0= $0
- Mod P000032014-03-28+$0= $0
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2011-11-15 | +$0 | $0 | RADIOPHARMACEUTICAL ISOTOPES FOR NUCLEAR MEDICINE AT SYRACUSE VAMC |
| Mod P00001· EXERCISE AN OPTION | 2012-12-01 | +$0 | $0 | RADIOPHARMACEUTICAL ISOTOPES FOR NUCLEAR MEDICINE AT SYRACUSE VAMC |
| Mod P00002· EXERCISE AN OPTION | 2013-10-01 | +$0 | $0 | RADIOPHARMACEUTICAL ISOTOPES FOR NUCLEAR MEDICINE AT SYRACUSE VAMC |
| Mod P00003· FUNDING ONLY ACTION | 2014-03-28 | +$0 | $0 | RADIOPHARMACEUTICAL ISOTOPES FOR NUCLEAR MEDICINE AT SYRACUSE VAMC |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI PNF5PJRFG3M7)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36C24224N0372 | 242-NETWORK CONTRACT OFFICE 02 (36C242) · 3650 · CHEMICAL AND PHARMACEUTICAL PRODUCTS MANUFACTURING MACHINERY | $141,413 | FY2024 |
| 36C24224D0034 | 242-NETWORK CONTRACT OFFICE 02 (36C242) · 3650 · CHEMICAL AND PHARMACEUTICAL PRODUCTS MANUFACTURING MACHINERY | $0 | FY2024 |
| 36C24121P0036 | 241-NETWORK CONTRACT OFFICE 01 (36C241) · 6505 · DRUGS AND BIOLOGICALS | $54,969 | FY2021 |
| 36C24220N0017 | 242-NETWORK CONTRACT OFFICE 02 (36C242) · 6505 · DRUGS AND BIOLOGICALS | $274,002 | FY2020 |
| 36C24219N0102 | 242-NETWORK CONTRACT OFFICE 02 (36C242) · 6505 · DRUGS AND BIOLOGICALS | $235,055 | FY2019 |
| VA24217J2952 | 242-NETWORK CONTRACT OFFICE 02 (36C242) · 6505 · DRUGS AND BIOLOGICALS | $101,950 | FY2018 |
Other recipients under 6505 from 242-NETWORK CONTRACT OFFICE 02 (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| VA52816F0890 | PFIZER INC | 242-NETWORK CONTRACT OFFICE 02 | $10,346 | FY2016 |
| VA52816F0808 | BAYER HEALTHCARE PHARMACEUTICALS INC | 242-NETWORK CONTRACT OFFICE 02 | $16,180 | FY2016 |
| VA52816F0388 | CSL BEHRING L.L.C. | 242-NETWORK CONTRACT OFFICE 02 | $1,097 | FY2016 |
| VA24016E0142 | MCKESSON CORPORATION | 242-NETWORK CONTRACT OFFICE 02 | $5,517,543 | FY2016 |
| VA52816J0701 | CEPHEID | 242-NETWORK CONTRACT OFFICE 02 | $234,636 | FY2016 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_IDV_VA52812D0032_3600 · retrieved 2026-09-26.